A U.S. Patent for "Large Scale Disposable Bioreactor" was awarded to Protalix on July 30th, 2019. The present invention is a reusable, disposable device for culturing plant tissues or cells including a non-rig

Alexandria made public this week that it is considering developing an up to 650,000-square-foot campus at 5, 10 and 15 Necco St. in Boston's Fort Point neighborhood. The company's leadership, on a conference call this week to discuss earnings, wen

Organization psychologist Jane Piper has worked with biopharma companies around the world to help them increase productivity and increase employee wellbeing. In this article she outlines the steps needed to increase productivity. In the biopharma

The Trump administration this week proposed allowing the importation of lower-priced drugs from foreign countries in its latest bid to lower patient out-of-pocket costs. The proposal rests on the belief that manufacturers would offer imported drug

Bayer announced this week that the U.S. FDA has approved under priority review the prostate cancer drug daroluramide, which Bayer had co-developed with Orion. This decision by the regulator makes Orion eligible for a $50 million milestone payment

The Federal Trade Commission (FTC) is investigating whether a Johnson & Johnson subsidiary violated antitrust laws with the contracting practices used for its anti-inflammation drug Remicade. J&J disclosed the legal challenge this week in

The US FDA has sent a Form 483 to API manufacturer Dr. Reddy's Bollaram, India site, raising concerns about the company's failure to respond to customer complaints about out-of-specification (OOS) results. According to the FDA, Dr. Reddy's receive

A U.S. Patent for "Ion Exchange Membrane Chromatography" was awarded to Genentech on July 30th, 2019. The present invention are methods of enhancing efficiency of downstream chromatography steps for purificat

A U.S. Patent Application for a "Method for Packing Chromatography Columns" was published by GE on July 25th, 2019. The present invention discloses a method for packing a plurality of uniform chromatography c

New research from the USC Viterbi School of Engineering could be key to our understanding of how the aging process works. The findings potentially pave the way for better cancer treatments and revolutionary new drugs that could vastly improve huma

A U.S. Patent Application for "Cell Culture Improvements" was published by AbbVie on July 25th, 2019. The present invention describes improved methods and compositions for producing a recombinant protein, e.g

Pfizer is understood to be in talks to merge its off-patent drugs business with Mylan in a stock deal. Mylan shareholders would receive a little more than 40% of the newly formed entity, with Pfizer shareholders receiving the remainder. Additional

Some of Switzerland's top university hospitals are teaming up to take on the soaring cost of cancer cell therapy offered by big pharma. The hospitals are hoping to offer the treatment for roughly $150,000 to $200,000. That's about one-third cheape

Genmab A/S has signed a long-term lease on a building at 777 Scudders Mill Road in Plainsboro, New Jersey that will serve as its U.S. headquarters office and host research lab. In doing so, Genmab becomes the first new tenant at the campus since t

Merck, known outside the United States and Canada as MSD, has announced plans to invest roughly $680 million and create more than 400 jobs in North Carolina. The biopharma industry leader will build a new production facility at its Maurice R. Hill

Vertex will promote Reshma Kewalramani, its chief medical officer, to president and CEO on April 1, the company announced this week. She will succeed Jeffrey Leiden, who said he would step down as president and CEO after seven years in those roles

Italian biopharma Zambon is acquiring Breath Therapeutics for $156 million up front to expand its respiratory pipeline and establish a foothold in the U.S. The terms of the deal give Zambon ownership of Breath's sole asset, liposomal cyclosporine

US FDA's CDER Director Janet Woodcock said this week that while the NIH has been instrumental to drug discovery and development, she does not think NIH or academics should be in the business of developing new pharmaceuticals. The comments came as

Industry leading biopharma Roche, along with a host of others, made public this week that they had been victims of cyber-attacks, confirming a German media report which said the likely culprit was a state-backed Chinese group. According to reports

The Fortune 500 list is compiled of the 500 U.S.-based companies that generate the most revenue. In the latest ranking, one dozen biopharma companies were included, with one, Johnson & Johnson, breaking into the top 50 and only four in the top

Lonza has announced the start of an expansion to its bioconjugation facility in Visp, Switzerland that is expected will take two years. The stated purpose of the expansion is to meet the development and manufacturing needs of pharma and biotech co

A U.S. Patent for "Perfusion Filtration Systems" was awarded to Artemis Biosystems on July 23rd, 2019. The present invention is a method of filtering a cell culture media comprising passing a cell culture med

The US FDA this week approved the 22nd and 23rd biosimilars: Pfizer's Ruxience, which is the second biosimilar to Roche's Rituxan, and Merck's Hadlima, which could end up being the ninth biosimilar to AbbVie's Humira. Celltrion and Teva's Truxima

The US FDA rejected an application from Biohaven for approval of its ALS drug, citing manufacturing quality issues with the active pharmaceutical ingredient used in a 2017 study, the biotech has disclosed. Biohaven said the sole issue raised by th

A U.S. Patent Application for an "Aseptic Bioreactor Sampling System" was published by Trizell on July 18th, 2019. The present invention is an adherent cell culture bioreactor comprising: a container having an interior for containing liquid c

The US FDA has approved the first generic versions of Pfizer's blockbuster pain drug Lyrica (pregabalin). The approvals were granted to Alembic Pharmaceuticals, Alkem Laboratories, Amneal Pharmaceuticals, Dr. Reddy's Laboratories, InvaGen Pharmace

Tuesday, July 30th, 2019

This webinar will review the history of biotherapeutics development to look for lessons we can learn that may accelerate advances in autologous cell therapy manuf